Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin dose comparison after endovascular treatment of intracranial aneurysm
ACTRN12621000478819Phase 3Recruiting
- Sponsor
- Royal Brisbane and Women's Hospital
- Start
- Feb 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of enoxaparin in brain aneurysm (IA) (2 arms), sponsored by Royal Brisbane and Women's Hospital. Primary endpoint: Proportion of patients with thromboembolic events on DWI MRI. Started Feb 2021; status: recruiting.
02
Drugs
enoxaparin
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on ACTRN12621000478819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000478819.